Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aprea Therapeutics, Inc.

1.53
+0.03002.00%
Post-market: 1.620.0900+5.88%19:44 EDT
Volume:38.48K
Turnover:60.33K
Market Cap:8.40M
PE:-0.65
High:1.65
Open:1.50
Low:1.45
Close:1.50
Loading ...
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2021

Major Issues Report

8-K - Current report
Dec 28, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report
Jun 30, 2020

Major Issues Report

8-K - Current report
Jun 16, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 22, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2020

Major Issues Report

8-K - Current report
Apr 03, 2020

Major Issues Report

Current report, item 8.01